TAKEDA PHARMACEUTIC-SP ADR (TAK) Institutional Ownership Changes & 13F Activity

TAKEDA PHARMACEUTIC-SP ADR (TAK) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC, Sequoia Financial Advisors, Hancock Classic Value, Causeway Capital Management, and ARK Invest.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCBuy370,8002,989,100$55,358,132
Q1 2026Sequoia Financial AdvisorsBuy15,70498,936$1,832,293
Q1 2026Hancock Classic ValueBuy7,73328,360$525,231
Q4 2025Renaissance Technologies LLCSell-1,246,3002,618,300$40,819,297
Q4 2025Sequoia Financial AdvisorsSell-20,63283,232$1,297,589
Q4 2025Hancock Classic ValueBuy20,62720,627$321,575
Q3 2025Renaissance Technologies LLCBuy565,4003,864,600$56,577,744
Q3 2025Sequoia Financial AdvisorsBuy5,814103,864$1,520,570
Q2 2025Renaissance Technologies LLCBuy141,5003,299,200$51,005,632
Q2 2025Sequoia Financial AdvisorsBuy33,45198,050$1,515,853
Q1 2025Renaissance Technologies LLCBuy78,3003,157,700$46,954,999
Q1 2025Sequoia Financial AdvisorsBuy26,65664,599$960,587
Q4 2024Causeway Capital ManagementSell-759,162522,030$6,911,684
Q4 2024Renaissance Technologies LLCSell-139,4003,079,400$40,771,256
Q4 2024Sequoia Financial AdvisorsBuy11,63737,943$502,366
Q3 2024Renaissance Technologies LLCBuy264,0003,218,800$45,771,336
Q3 2024Causeway Capital ManagementSell-72,9721,281,192$18,218,553
Q3 2024Sequoia Financial AdvisorsBuy3,31826,306$374,072
Q2 2024Renaissance Technologies LLCSell-163,4002,954,800$38,235,112
Q2 2024Causeway Capital ManagementSell-90,7441,354,164$17,522,888
Q2 2024Sequoia Financial AdvisorsBuy59222,988$297,465
Q1 2024Renaissance Technologies LLCSell-209,2003,118,200$43,312
Q1 2024Causeway Capital ManagementBuy99,2631,444,908$20,069,770
Q1 2024Sequoia Financial AdvisorsBuy2,15922,396$311,079
Q4 2023Causeway Capital ManagementBuy101,3361,345,645$19,202,354
Q4 2023Renaissance Technologies LLCBuy96,5003,327,400$47,482
Q4 2023Sequoia Financial AdvisorsSell-4,13720,237$288,780
Q3 2023Renaissance Technologies LLCSell-419,1003,230,900$49,982
Q3 2023Causeway Capital ManagementBuy123,7251,244,309$19,249,467
Q3 2023Sequoia Financial AdvisorsBuy1,35324,374$377,066

Frequently asked questions about TAK activity

  • Which institutional owners are buying TAK?

    Institutional owners buying TAK include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TAK activity?

    "Buy" means an investor increased their reported position in TAK compared to the prior reporting period. This reflects growing exposure to TAKEDA PHARMACEUTIC-SP ADR (TAK) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TAK increasing?

    Institutional interest in TAK can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related TAK insights